Twist Bioscience (TWST) Profit Margin (2017 - 2026)
Twist Bioscience (TWST) profit margin from Dec 31, 2017 to Mar 31, 2026. The current Twist Bioscience (TWST) profit margin is -39.76%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Twist Bioscience (TWST)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -20.63% | -69.07% |
| 2024 | -66.69% | -20.11% |
| 2023 | -83.48% | -21.99% |
| 2022 | -107.02% | N/A |
| 2022 | -107.02% | -6.89% |
| 2021 | -114.94% | N/A |
| 2021 | -114.94% | -25.99% |
| 2020 | -155.31% | N/A |
| 2020 | -155.31% | -21.55% |
| 2019 | -197.96% | -29.34% |
| 2018 | -280.14% | -49.13% |
| 2017 | -550.70% | N/A |
Comparison Twist Bioscience (TWST) profit margin with competitors
Twist Bioscience (TWST) profit margin is -39.76%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 24.41% | -161.40% |
| VCYT | Veracyte Inc | 20.64% | -151.91% |
| QGEN | Qiagen NV | 20.33% | -151.13% |
| MTD | Mettler-Toledo International Inc | 17.89% | -145.00% |
| MEDP | Medpace Holdings Inc | 17.53% | -144.09% |
| DHR | Danaher Corp | 17.29% | -143.49% |
| A | Agilent Technologies Inc | 16.96% | -142.66% |
| BLLN | Billiontoone Inc - Class A | 16.58% | -141.70% |
| TMO | Thermo Fisher Scientific Inc | 15.00% | -137.73% |
| ILMN | Illumina Inc | 12.28% | -130.89% |
| SHC | Sotera Health Company | 9.49% | -123.87% |
| DGX | Quest Diagnostics Inc | 8.70% | -121.88% |
| LH | Laboratory Corp Of America Holdings | 7.85% | -119.74% |
| IQV | IQVIA Holdings Inc | 6.60% | -116.60% |
| FONR | Fonar Corp | 6.20% | -115.59% |
| RVTY | Revvity Inc | 5.73% | -114.41% |
| ICLR | Icon Plc | 2.78% | -106.99% |
| CDNA | Caredx Inc | 2.39% | -106.01% |